Opinions and Legal Insights

Latham & Watkins Advises Underwriters in Foghorn Therapeutics’ IPO

Foghorn Therapeutics Inc., a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, has announced the pricing of […]

The post Latham & Watkins Advises Underwriters in Foghorn Therapeutics’ IPO appeared first on Legal Desire.